<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">Huang 
 <italic>et al.</italic>
 <xref rid="b0285" ref-type="bibr">[57]</xref> reported that acute respiratory distress syndrome (ARDS) was the most common complication in COVID-19 patients 
 <xref rid="b0290" ref-type="bibr">[58]</xref>, followed by anemia, acute cardiac injury, and secondary infections. Hence, empirical antibiotics, antiviral drugs, and systemic corticosteroids are used as treatments 
 <xref rid="b0295" ref-type="bibr">[59]</xref>. Moreover, Holshue 
 <italic>et al.</italic>
 <xref rid="b0300" ref-type="bibr">[60]</xref> suggested the use of invasive mechanical ventilation for patients with intractable hypoxemia. So, the treatments of patients with COVID-19 infection are mainly symptomatic in nature.
</p>
